A Post-Authorization Safety Surveillance Study to Report Clinical Experience with Purified Factor IX Concentrate in Pediatric Patients with Hemophilia B by Igrutinović Z, Hooimeijer HL, Kentouche K, Botha J, Turecek PL, Kokot-Kierepa M, Gazda HT

Get full text

The spectrum of neutralizing and non-neutralizing anti-FVIII antibodies in a nationwide cohort of 788 persons with hemophilia A by Oomen, I, Verhagen, M, Miranda, M, Allacher, P, Beckers, EAM, Blijlevens, NMA, Bom, JGVD, Coppens, M, Driessens, M, Eikenboom, JCJ, Fijnvandraat, K, Hassan, S, van Heerde, WL, Hooimeijer, HL, Jansen, JH, Kaijen, P, Leebeek, FWG, Meijer, D, Paul, H, Rijpma, SR, Rosendaal, FR, Smit, C, van Vulpen, LFD, Voorberg, J